The following four items have been discussed ; 1) the quite different incidence of CLL morbidity in Japanese and Caucasian, approximately 0.1 vs 15 per millions ; 2) the different frequency of CLL subtype, atypical CLL of CLL/PL and CLLmixed inclusive of cases with aberrant immunophenotypes such as CD5 negative are relatively high in Japan ; 3) the different autoimmune complications in race such as hemolytic anemia with positive anti -globulin test ; and 4) biomolecularly characterization of CLL cells derived Japanese and 
